We are live on ! Find out more
MGLN

Magellan Health Services, Inc.

Delisted

MGLN was delisted on the 3rd of January, 2022.

204 hedge funds and large institutions have $1.53B invested in Magellan Health Services, Inc. in 2016 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 83 increasing their positions, 67 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 12

24% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 67

17% more call options, than puts

Call options by funds: $899K | Put options by funds: $770K

7% more funds holding

Funds holding: 191204 (+13)

4% less capital invested

Capital invested by funds: $1.59B → $1.53B (-$57.4M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
204
Holders Change
+13
Holders Change %
+6.81%
% of All Funds
5.44%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
26
Increased
83
Reduced
67
Closed
12
Calls
$899K
Puts
$770K
Net Calls
+$129K
Net Calls Change
-$1.67M
Name Holding Trade Value Shares
Change
Change in
Stake
VKH
151
Virtu KCG Holdings
New York
$434K +$444K +6,598 New
OPERF
152
Oregon Public Employees Retirement Fund
Oregon
$416K
AW
153
Alpha Windward
Massachusetts
$410K -$60.6K -900 -13%
HIM
154
Hillsdale Investment Management
Ontario, Canada
$408K
FIM
155
Freedom Investment Management
Connecticut
$386K +$12.7K +188 +3%
Public Employees Retirement Association of Colorado
156
Public Employees Retirement Association of Colorado
Colorado
$382K
PC
157
Palo Capital
California
$378K +$386K +5,734 New
Squarepoint
158
Squarepoint
New York
$350K +$143K +2,124 +66%
SSG
159
Summit Securities Group
New York
$347K +$356K +5,280 New
PCM
160
Prelude Capital Management
New York
$343K +$45.2K +672 +15%
SG Americas Securities
161
SG Americas Securities
New York
$331K -$40.6K -603 -11%
SG
162
Societe Generale
$331K +$339K +5,035 New
Federated Hermes
163
Federated Hermes
Pennsylvania
$318K +$202K +2,996 +162%
HCM
164
Highbridge Capital Management
New York
$318K +$325K +4,826 New
MSA
165
Mason Street Advisors
Wisconsin
$317K +$28.2K +419 +10%
CG
166
Clinton Group
New York
$301K +$308K +4,577 New
ProShare Advisors
167
ProShare Advisors
Maryland
$298K +$19.7K +293 +7%
MC
168
Menta Capital
California
$288K +$295K +4,375 New
CMBA
169
C.M. Bidwell & Associates
Hawaii
$268K +$275K +4,080 New
Marshall Wace
170
Marshall Wace
United Kingdom
$258K +$264K +3,922 New
Envestnet Asset Management
171
Envestnet Asset Management
Illinois
$251K +$44.4K +660 +21%
BlackRock
172
BlackRock
New York
$228K +$134K +1,994 +135%
Teacher Retirement System of Texas
173
Teacher Retirement System of Texas
Texas
$221K +$19.4K +288 +9%
PI
174
PineBridge Investments
New York
$205K +$7.81K +116 +4%
CIBC Asset Management
175
CIBC Asset Management
Ontario, Canada
$202K

MGLN Hedge Fund Activity: Q2 2016 in Review

204 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Magellan Health Services, Inc. (MGLN) for Q2 2016, worth a combined $1.53B — down 3.6% from $1.59B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new MGLN positions and 12 closed out — a net gain of 14 holders — while 83 added to existing stakes and 67 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $10.1M. The largest seller was OrbiMed, cutting an estimated $55.1M.

  • 204 institutional investors held Magellan Health Services, Inc. (MGLN) as of Q2 2016, up from 191 in Q1 2016.
  • Funds reported $1.53B of Magellan Health Services, Inc. stock for Q2 2016, down 3.6% quarter-over-quarter.
  • 26 funds opened new Magellan Health Services, Inc. positions in Q2 2016 and 12 closed out, a net change of +14 holders.
  • The largest Magellan Health Services, Inc. buyer in Q2 2016 was Arrowstreet Capital, an estimated $10.1M added.
  • The largest Magellan Health Services, Inc. seller in Q2 2016 was OrbiMed, an estimated $55.1M sold.

Based on aggregated 13F filings for Q2 2016.